Policy Analysis: Investment, Life Sciences, Policy
Horizon 2020 Special Coverage
Horizon 2020 – New Commission, new Agenda
The 2015 Science|Business Horizon 2020 Conference
Brussels - 24 March 2015
Aalto University Academic Summit (Partner Event)
The summit will focus on how universities contribute in creating knowledge societies thereby facilitating economic development, job creation and well-being.
Espoo, Finland - 18 November 2014
The EU Energy Challenge: Can innovation fill the gap?
The EU’s transition to a sustainable energy system is a top policy challenge of the coming decade. Though much progress has been achieved, the pace of change is too slow.
Square - Brussels Meeting Centre - 14 November 2014
Helping Europe Innovate
The Annual Report 2013-2014 is a summary of the activites of the Science|Business Innovation Board over the past year. The Science|Business...
Published:
Pharma industry agrees collaboration to tackle non-communicable disease

The pharmaceutical sector launched a Framework for Action to tackle non-communicable diseases including cardiovascular disease, cancer, diabetes and chronic respiratory diseases that are posing a threat to public health, and public and private finances worldwide.


Image: Bigstock

The industry’s ten-point framework scopes out specific areas of action including innovation, access and affordability of drugs, prevention and health education. It also underscores the essential role of partnerships and dialogue in implementing the framework.

The framework confirms the industry’s crucial role in continued investment in R&D programmes to develop drugs for the prevention and treatment of non-communicable disease, with over 1,500 products in the pipeline currently. It also commits the industry to target its innovation towards...



Related subjects: Cancer, Diabetes, chronic respiratory disease, non-communicable disease

Advertisement